Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 10/17 10:00:30 pm
140.79 USD   +3.43%
02:03p UNITEDHEALTH : Agloan-Dow, S&P Reach New Highs
10:13a JOHNSON & JOHNS : Briefly Briefly
08:48aDJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales74 33170 07471 89075 88480 08983 571
EBITDA25 48624 10925 60026 43728 87830 967
Operating profit (EBIT)21 59120 36323 11722 95125 05026 595
Pre-Tax Profit (EBT)------
Net income16 32315 40916 54016 41219 95021 752
P/E ratio18,318,719,423,518,817,4
EPS ( $ )5,705,485,935,997,488,08
Dividend per Share ( $ )2,762,953,153,353,603,83
Yield2,64%2,87%2,73%2,38%2,56%2,72%
Reference price ( $ )104.57102.72115.21140.79140.79140.79
Announcement Date01/20/2015
12:45pm
01/26/2016
11:40am
01/24/2017
11:40am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt---17 9289 170-
Finance14 32918 51514 781--4 977
Operating income (EBITDA)25 48624 10925 60026 43728 87830 967
Leverage
(Debt/EBITDA)
---0,68x0,32x-
Capital Expenditure3 7143 4633 2263 3353 5323 544
Book Value Per Share (BVPS)25,1 $25,8 $26,0 $27,4 $30,8 $34,5 $
Cash Flow per Share6,45 $6,85 $6,73 $7,05 $8,86 $9,56 $
Announcement Date01/20/2015
12:45pm
01/26/2016
11:40am
01/24/2017
11:40am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 377 880 M$ -
Entreprise Value (EV) 395 808 M$ 387 050 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 23,5x 18,8x
Capitalization / Revenue 4,98x 4,72x
EV / Revenue 5,22x 4,83x
EV / EBITDA 15,0x 13,4x
Yield (DPS / Price) 2,38% 2,56%
Price to book (Price / BVPS) 5,13x 4,57x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 30,2% 31,3%
operating Leverage (Delta EBIT / Delta Sales) - 1,65x
Net Margin (Net Profit / Revenue) 21,6% 24,9%
ROA (Net Profit / Asset) 12,9% 14,0%
ROE (Net Profit / Equities) 26,3% 28,0%
Rate of Dividend 55,8% 48,1%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   4,39% 4,41%
Cash Flow / Sales 24,9% 29,7%
Capital Intensity (Assets / Sales) 1,68x 1,78x
Financial Leverage (Net Debt / EBITDA) 0,68x 0,32x
EPS & Dividend